Matches in SemOpenAlex for { <https://semopenalex.org/work/W2425197203> ?p ?o ?g. }
- W2425197203 endingPage "54003" @default.
- W2425197203 startingPage "53989" @default.
- W2425197203 abstract "The SET (I2PP2A) oncoprotein is a potent inhibitor of protein phosphatase 2A (PP2A) that regulates many cell processes and important signaling pathways. Despite the importance of SET overexpression and its prognostic impact in both hematologic and solid tumors, little is known about the mechanisms involved in its transcriptional regulation. In this report, we define the minimal promoter region of the SET gene, and identify a novel multi-protein transcription complex, composed of MYC, SP1, RUNX1 and GATA2, which activates SET expression in AML. The role of MYC is crucial, since it increases the expression of the other three transcription factors of the complex, and supports their recruitment to the promoter of SET. These data shed light on a new regulatory mechanism in cancer, in addition to the already known PP2A-MYC and SET-PP2A. Besides, we show that there is a significant positive correlation between the expression of SET and MYC, RUNX1, and GATA2 in AML patients, which further endorses our results. Altogether, this study opens new directions for understanding the mechanisms that lead to SET overexpression, and demonstrates that MYC, SP1, RUNX1 and GATA2 are key transcriptional regulators of SET expression in AML." @default.
- W2425197203 created "2016-06-24" @default.
- W2425197203 creator A5007823968 @default.
- W2425197203 creator A5016683229 @default.
- W2425197203 creator A5027377475 @default.
- W2425197203 creator A5028939517 @default.
- W2425197203 creator A5042934316 @default.
- W2425197203 creator A5043296656 @default.
- W2425197203 creator A5082797212 @default.
- W2425197203 creator A5088764876 @default.
- W2425197203 date "2016-06-06" @default.
- W2425197203 modified "2023-10-16" @default.
- W2425197203 title "MYC-dependent recruitment of RUNX1 and GATA2 on the SET oncogene promoter enhances PP2A inactivation in acute myeloid leukemia" @default.
- W2425197203 cites W1255676896 @default.
- W2425197203 cites W1876581925 @default.
- W2425197203 cites W1900480423 @default.
- W2425197203 cites W1964241796 @default.
- W2425197203 cites W1964733653 @default.
- W2425197203 cites W1964824076 @default.
- W2425197203 cites W1975748957 @default.
- W2425197203 cites W1975923812 @default.
- W2425197203 cites W1980583475 @default.
- W2425197203 cites W1981083415 @default.
- W2425197203 cites W1982766090 @default.
- W2425197203 cites W1985911963 @default.
- W2425197203 cites W1987474302 @default.
- W2425197203 cites W1990353372 @default.
- W2425197203 cites W1999327797 @default.
- W2425197203 cites W2001122852 @default.
- W2425197203 cites W2004061637 @default.
- W2425197203 cites W2005748458 @default.
- W2425197203 cites W2010440090 @default.
- W2425197203 cites W2013713190 @default.
- W2425197203 cites W2013856346 @default.
- W2425197203 cites W2025063645 @default.
- W2425197203 cites W2031380298 @default.
- W2425197203 cites W2034108356 @default.
- W2425197203 cites W2034174983 @default.
- W2425197203 cites W2034620858 @default.
- W2425197203 cites W2034995391 @default.
- W2425197203 cites W2038250831 @default.
- W2425197203 cites W2039994380 @default.
- W2425197203 cites W2043263167 @default.
- W2425197203 cites W2047013481 @default.
- W2425197203 cites W2047688922 @default.
- W2425197203 cites W2047816695 @default.
- W2425197203 cites W2050404969 @default.
- W2425197203 cites W2051818083 @default.
- W2425197203 cites W2051890221 @default.
- W2425197203 cites W2053645860 @default.
- W2425197203 cites W2054177883 @default.
- W2425197203 cites W2057742004 @default.
- W2425197203 cites W2063692415 @default.
- W2425197203 cites W2063807995 @default.
- W2425197203 cites W2070516871 @default.
- W2425197203 cites W2071183768 @default.
- W2425197203 cites W2071733232 @default.
- W2425197203 cites W2071779883 @default.
- W2425197203 cites W2076076392 @default.
- W2425197203 cites W2083069127 @default.
- W2425197203 cites W2083459920 @default.
- W2425197203 cites W2083832170 @default.
- W2425197203 cites W2086223460 @default.
- W2425197203 cites W2087646825 @default.
- W2425197203 cites W2094546718 @default.
- W2425197203 cites W2097616526 @default.
- W2425197203 cites W2105003436 @default.
- W2425197203 cites W2105214585 @default.
- W2425197203 cites W2108146440 @default.
- W2425197203 cites W2109972881 @default.
- W2425197203 cites W2110909186 @default.
- W2425197203 cites W2112327611 @default.
- W2425197203 cites W2113197426 @default.
- W2425197203 cites W2113907907 @default.
- W2425197203 cites W2114625809 @default.
- W2425197203 cites W2116247281 @default.
- W2425197203 cites W2122616238 @default.
- W2425197203 cites W2124193450 @default.
- W2425197203 cites W2135030836 @default.
- W2425197203 cites W2144965236 @default.
- W2425197203 cites W2148850881 @default.
- W2425197203 cites W2155205071 @default.
- W2425197203 cites W2160697532 @default.
- W2425197203 cites W2162544653 @default.
- W2425197203 cites W4210767115 @default.
- W2425197203 cites W4231346141 @default.
- W2425197203 doi "https://doi.org/10.18632/oncotarget.9840" @default.
- W2425197203 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5589557" @default.
- W2425197203 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28903318" @default.
- W2425197203 hasPublicationYear "2016" @default.
- W2425197203 type Work @default.
- W2425197203 sameAs 2425197203 @default.
- W2425197203 citedByCount "26" @default.
- W2425197203 countsByYear W24251972032016 @default.
- W2425197203 countsByYear W24251972032017 @default.
- W2425197203 countsByYear W24251972032018 @default.
- W2425197203 countsByYear W24251972032020 @default.
- W2425197203 countsByYear W24251972032021 @default.